Chloé Chong

University Hospital of Lausanne — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index2.1kcitations28works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

vaccines and immunoinformatics approaches(16), Immunotherapy and Immune Responses(13), Peptidase Inhibition and Analysis(9), Cancer Immunotherapy and Biomarkers(4), Monoclonal and Polyclonal Antibodies Research(4)

Publications28 total

The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
Nature Cancer·2023· 69 citedOpen Access
Improved NGS-based detection of microsatellite instability using tumor-only data
Frontiers in Oncology·2022· 16 citedOpen Access
Enzymatic processing and MHC loading in cancer immunotherapyAdvanced immunopeptidomics based discovery engine for the development of personalized cancer immunotherapy
Molecular Immunology·2022
A deep learning approach for improved detection of homologous recombination deficiency from shallow genomic profiles
2022· 2 citedOpen Access
Sensitive identification of neoantigens and cognate TCRs in human solid tumors
Nature Biotechnology·2021· 95 citedOpen Access
Identification of tumor antigens with immunopeptidomics
Nature Biotechnology·2021· 210 cited
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
Cell Reports·2021· 127 citedOpen Access
Can Decentralisation Be a Force for Bad? New Evidence from Decentralising Environmental Clearances in India
SSRN Electronic Journal·2021· 2 citedOpen Access
Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction
Molecular & Cellular Proteomics·2021· 88 citedOpen Access
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
Nature Communications·2020· 313 citedOpen Access
An Integrated Immunopeptidomics and Proteogenomics Framework to Discover Non-Canonical Targets for Cancer Immunotherapy
SERVAL (Université de Lausanne)·2020Open Access
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Nature Biotechnology·2019· 292 cited
Immunogenicity of BRCA1-deficient ovarian cancers is driven through DNA sensing and is augmented by PARP inhibition
Annals of Oncology·2019· 1 citedOpen Access
Integrated Proteogenomic Deep Sequencing and Analytics Accurately Identify Non-Canonical Peptides in Tumor Immunopeptidomes
2019· 37 citedOpen Access
Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
British Journal of Cancer·2019· 1 citedOpen Access
Deep motif deconvolution of HLA-II peptidomes for robust class II epitope predictions
2019· 8 citedOpen Access
Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
British Journal of Cancer·2019· 68 citedOpen Access
High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry
Methods in molecular biology·2019· 31 cited
Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome*
Molecular & Cellular Proteomics·2018· 97 citedOpen Access
Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome
2018· 14 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Michal Bassani‐Sternberg(20), George Coukos(18), Markus Müller(9), HuiSong Pak(8), Justine Michaux(8), David Gfeller(8), Brian J. Stevenson(6), Alexandre Harari(6), Florian Huber(5), Marion Arnaud(5), Ioannis Xénarios(4), Julien Racle(4), Sara Bobisse(4), Philippe Guillaume(4), Lana E. Kandalaft(4), Laia Simó‐Riudalbas(3), Evarist Planet(3), Maciej Wiznerowicz(3), Didier Trono(3), Fabio Marino(3)